BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33763779)

  • 1. Extended gene panel testing in lobular breast cancer.
    van Veen EM; Evans DG; Harkness EF; Byers HJ; Ellingford JM; Woodward ER; Bowers NL; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ
    Fam Cancer; 2022 Apr; 21(2):129-136. PubMed ID: 33763779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline testing of
    Woodward ER; Lalloo F; Forde C; Pugh S; Burghel GJ; Schlecht H; Harkness EF; Howell A; Howell SJ; Gandhi A; Evans DG
    J Med Genet; 2024 Mar; 61(4):385-391. PubMed ID: 38123987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.
    Yadav S; Hu C; Nathanson KL; Weitzel JN; Goldgar DE; Kraft P; Gnanaolivu RD; Na J; Huang H; Boddicker NJ; Larson N; Gao C; Yao S; Weinberg C; Vachon CM; Trentham-Dietz A; Taylor JA; Sandler DR; Patel A; Palmer JR; Olson JE; Neuhausen S; Martinez E; Lindstrom S; Lacey JV; Kurian AW; John EM; Haiman C; Bernstein L; Auer PW; Anton-Culver H; Ambrosone CB; Karam R; Chao E; Yussuf A; Pesaran T; Dolinsky JS; Hart SN; LaDuca H; Polley EC; Domchek SM; Couch FJ
    J Clin Oncol; 2021 Dec; 39(35):3918-3926. PubMed ID: 34672684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
    Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E
    Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
    Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
    JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
    Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
    JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery.
    Irelli A; Patruno LV; Chiatamone Ranieri S; Di Giacomo D; Malatesta S; Alesse E; Tessitore A; Cannita K
    Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Population-Based Study of Genes Previously Implicated in Breast Cancer.
    Hu C; Hart SN; Gnanaolivu R; Huang H; Lee KY; Na J; Gao C; Lilyquist J; Yadav S; Boddicker NJ; Samara R; Klebba J; Ambrosone CB; Anton-Culver H; Auer P; Bandera EV; Bernstein L; Bertrand KA; Burnside ES; Carter BD; Eliassen H; Gapstur SM; Gaudet M; Haiman C; Hodge JM; Hunter DJ; Jacobs EJ; John EM; Kooperberg C; Kurian AW; Le Marchand L; Lindstroem S; Lindstrom T; Ma H; Neuhausen S; Newcomb PA; O'Brien KM; Olson JE; Ong IM; Pal T; Palmer JR; Patel AV; Reid S; Rosenberg L; Sandler DP; Scott C; Tamimi R; Taylor JA; Trentham-Dietz A; Vachon CM; Weinberg C; Yao S; Ziogas A; Weitzel JN; Goldgar DE; Domchek SM; Nathanson KL; Kraft P; Polley EC; Couch FJ
    N Engl J Med; 2021 Feb; 384(5):440-451. PubMed ID: 33471974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
    Palmer JR; Polley EC; Hu C; John EM; Haiman C; Hart SN; Gaudet M; Pal T; Anton-Culver H; Trentham-Dietz A; Bernstein L; Ambrosone CB; Bandera EV; Bertrand KA; Bethea TN; Gao C; Gnanaolivu RD; Huang H; Lee KY; LeMarchand L; Na J; Sandler DP; Shah PD; Yadav S; Yang W; Weitzel JN; Domchek SM; Goldgar DE; Nathanson KL; Kraft P; Yao S; Couch FJ
    J Natl Cancer Inst; 2020 Dec; 112(12):1213-1221. PubMed ID: 32427313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating genetic variants associated with breast cancer risk in high and moderate-penetrance genes in Asians.
    Han MR; Zheng W; Cai Q; Gao YT; Zheng Y; Bolla MK; Michailidou K; Dennis J; Wang Q; Dunning AM; Brennan P; Chen ST; Choi JY; Hartman M; Ito H; Lophatananon A; Matsuo K; Miao H; Muir K; Sangrajrang S; Shen CY; Teo SH; Tseng CC; Wu AH; Yip CH; Kang D; Xiang YB; Easton DF; Shu XO; Long J
    Carcinogenesis; 2017 May; 38(5):511-518. PubMed ID: 28419251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients.
    Satake T; Kondo S; Tanabe N; Mizuno T; Katsuya Y; Sato J; Koyama T; Yoshida T; Hirata M; Yamamoto N
    Cancer Res Commun; 2023 Nov; 3(11):2302-2311. PubMed ID: 37916805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Clinical Utility of Reporting Hereditary Cancer Predisposition Pathogenic Variants Identified in Research Germline Sequencing: A Prospective Interventional Study.
    Hutchcraft ML; Zhang S; Lin N; Pickarski JC; Belcher EA; Wei S; Bocklage T; Miller RW; Villano JL; Cavnar MJ; Kim J; Arnold SM; Ueland FR; Kolesar JM
    JCO Precis Oncol; 2024 Jan; 8():e2300266. PubMed ID: 38295319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.
    Augustinsson A; Loman N; Ehrencrona H
    Breast Cancer Res Treat; 2024 Jun; 205(3):599-607. PubMed ID: 38491334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary breast cancer: syndromes, tumour pathology and molecular testing.
    Sokolova A; Johnstone KJ; McCart Reed AE; Simpson PT; Lakhani SR
    Histopathology; 2023 Jan; 82(1):70-82. PubMed ID: 36468211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal Germline-Genetic Testing for Breast Cancer: Implementation in a Rural Practice and Impact on Shared Decision-Making.
    Shelton C; Ruiz A; Shelton L; Montgomery H; Freas K; Ellsworth RE; Poll S; Pineda-Alvarez D; Heald B; Esplin ED; Nielsen SM
    Ann Surg Oncol; 2024 Jan; 31(1):325-334. PubMed ID: 37814187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
    Nielsen SM; Eccles DM; Romero IL; Al-Mulla F; Balmaña J; Biancolella M; Bslok R; Caligo MA; Calvello M; Capone GL; Cavalli P; Chan TLC; Claes KBM; Cortesi L; Couch FJ; de la Hoya M; De Toffol S; Diez O; Domchek SM; Eeles R; Efremidis A; Fostira F; Goldgar D; Hadjisavvas A; Hansen TVO; Hirasawa A; Houdayer C; Kleiblova P; Krieger S; Lázaro C; Loizidou M; Manoukian S; Mensenkamp AR; Moghadasi S; Monteiro AN; Mori L; Morrow A; Naldi N; Nielsen HR; Olopade OI; Pachter NS; Palmero EI; Pedersen IS; Piane M; Puzzo M; Robson M; Rossing M; Sini MC; Solano A; Soukupova J; Tedaldi G; Teixeira M; Thomassen M; Tibiletti MG; Toland A; Törngren T; Vaccari E; Varesco L; Vega A; Wallis Y; Wappenschmidt B; Weitzel J; Spurdle AB; De Nicolo A; Gómez-García EB
    JCO Precis Oncol; 2018; 2():. PubMed ID: 31517176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study.
    Abdel-Razeq H; Sharaf B; Bani Hani H; Abu Hijlih R; Alkyam M; Al-Azzam K; Elemian S; Tbakhi A; Al-Atary A; Ellsworth RE; Russell EM; Esplin ED; Horani M; Zeidan Z; Alzibdeh A; Heald B; Nielsen SM; Nussbaum RL
    JCO Glob Oncol; 2024 Jun; 10():e2400068. PubMed ID: 38843472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape.
    Abu-Hijlih R; Sharaf B; Salah S; Bani Hani H; Alqaisieh M; Alzibdeh A; Ababneh L; Mahafdah S; Abdel-Razeq H
    Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental pathogenic germline alterations detected through liquid biopsy in patients with solid tumors: prevalence, clinical utility and implications.
    Laguna JC; Pastor B; Nalda I; Hijazo-Pechero S; Teixido C; Potrony M; Puig-Butillé JA; Mezquita L
    Br J Cancer; 2024 May; 130(9):1420-1431. PubMed ID: 38532104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of a universal germline screening program in a community urology practice.
    Mendhiratta N; Hauver H; Hatton W; Ostrusky A; Sathe DS; Gurram S; Rice P; Chalfin H
    Clin Genet; 2024 May; ():. PubMed ID: 38711401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.